Cargando…
Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
PURPOSE: To evaluate the intraocular pressure (IOP)-lowering effect of adding dorzolamide 1.0%/timolol 0.5% fixed combination (DTFC) to prostaglandin analogs (PGAs) as monotherapy in patients with normal tension glaucoma. METHODS: A prospective, clinical, case-controlled study of patients with norma...
Autores principales: | Mizoguchi, Takanori, Ozaki, Mineo, Wakiyama, Harumi, Ogino, Nobuchika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206124/ https://www.ncbi.nlm.nih.gov/pubmed/22069355 http://dx.doi.org/10.2147/OPTH.S24058 |
Ejemplares similares
-
Plateau iris in Japanese patients with primary angle closure and primary angle closure glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2015) -
Peripheral iris thickness and association with iridotrabecular contact after laser peripheral iridotomy in patients with primary angle-closure and primary angle-closure glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2014) -
Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017) -
Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma
por: Yeh, Jason, et al.
Publicado: (2008) -
Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi, Takanori, et al.
Publicado: (2017)